Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Canopus Biopharma Inc (CBIA)
OTHER OTC:CBIA
Canopus Biopharma (CBIA) Stock Price & Analysis
17 Followers
CBIA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.22
Previous Close$0.01
Volume259.17M
Average Volume (3M)N/A
Market Cap
$814.67K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-1.1
Beta2.91
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares OutstandingN/A
10 Day Avg. Volume232,428,652
30 Day Avg. VolumeN/A
Standard Deviation2.20
R-Squared0.00420
Alpha0.49
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
CBIA FAQ
What was Canopus Biopharma Inc’s price range in the past 12 months?
Canopus Biopharma Inc lowest stock price was <$0.01 and its highest was $0.22 in the past 12 months.
What is Canopus Biopharma Inc’s market cap?
Currently, no data Available
When is Canopus Biopharma Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Canopus Biopharma Inc’s earnings last quarter?
Currently, no data Available
Is Canopus Biopharma Inc overvalued?
According to Wall Street analysts Canopus Biopharma Inc’s price is currently Overvalued.
Does Canopus Biopharma Inc pay dividends?
Canopus Biopharma Inc does not currently pay dividends.
What is Canopus Biopharma Inc’s EPS estimate?
Canopus Biopharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Canopus Biopharma Inc have?
Canopus Biopharma Inc has 2,327,639,200 shares outstanding.
What happened to Canopus Biopharma Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Canopus Biopharma Inc?
Currently, no hedge funds are holding shares in CBIA
---
Company Description
Canopus Biopharma Inc
Canopus Biopharma, Inc. develops pharmaceuticals in the areas of antiviral, radiation protection, cancer therapies, camelidae blood products and bio-barcode assay technologies. It provides pharmaceutical products and assay methods to patients suffering from infectious disease, cancer. The company was founded on April 8, 1986 and is headquartered in Santa Monica, CA.
---
---